-

Status

Not yet recruiting

Phases

Phase 4

Study type

Interventional

Source

EU CTR

Registry ID

EUCTR2018-001280-22-FI

Enrollment

Registered

2018-06-29

Start date

2018-08-22

Completion date

Unknown

Last updated

2021-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Trade Name: Instanyl 100 mikrog/annos Pharmaceutical Form: Nasal/oromucosal spray, solution INN or Proposed INN: fentanyyli Other descriptive name: FENTANYL CITRATE Trade Name: Fentanyl hameln 50 mik

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: - Are the trial subjects under 18? no Number of subjects for this age range: F.1.2 Adults (18-64 years) yes F.1.2.1 Number of subjects for this age range 30 F.1.3 Elderly (>=65 years) yes F.1.3.1 Number of subjects for this age range 30

Exclusion criteria

Exclusion criteria: -

Design outcomes

Primary

Measure	Time frame
Main Objective: -;Secondary Objective: -;Primary end point(s): .;Timepoint(s) of evaluation of this end point: -	—

Secondary

Measure	Time frame
Secondary end point(s): -;Timepoint(s) of evaluation of this end point: -	—

Countries

Finland

Contacts

Public ContactMerja Kokki

Kuopio University Hospital

merja.kokki@kuh.fi3584471747464

Outcome results